Kedrion Biopharma Revenue, Growth & Competitor Profile

DBA KEDRION GROUP SPA

Company Profile & Annual Report for Kedrion Biopharma

Access the complete profile.

Kedrion Biopharma Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	Over 1,000Exact Company Size
Primary Industry	621 Ambulatory Health Care Services
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	400 Kelby Street Ste. G Fort Lee, NJ 07024

Note: Revenues for privately held companies are statistical evaluations.


Kedrion Biopharma's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Kedrion Biopharma's annual revenues are $100 - $500 million (see exact revenue data)
• What industry is the company in?
  • Kedrion Biopharma is classified as operating in the Ambulatory Health Care Services industry, NAICS Code 621.

Kedrion Biopharma Annual Revenue and Growth Rate

Kedrion Biopharma	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$100 - $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Kedrion Biopharma's revenues are gauged from an analysis of company filings.

Kedrion Biopharma's Income Statement (based on Industry Averages)

Kedrion Biopharma P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Kedrion Biopharma is developing and marketing. Kedrion Biopharma doesn't have any recent trademark applications, indicating Kedrion Biopharma is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
KEDBUMIN Pharmaceutical preparations, namely, albumin for humans for the treatment of hypovolemia and hypoalbuminemia, prevention of central volume depletion after paracentesis due to cirrhotic ascites, Ovarian hyperstimulation syndrome (OHSS), Adult Respiratory Distress Syndrome (ARDS), burns, hemodialysis patients undergoing long term dialysis, patients who cannot tolerate substantial volumes of salt solution and priming as part of a cardiopulmonary bypass fluids	05/25/2011
MICRHOGAM IMMUNE GLOBULIN (HUMAN)	10/31/1973
RHOGAM GAMMA GLOBULIN INJECTABLE SOLUTIONS	08/24/1966

See all trademarks and details in the Full Report.

Market Share of Kedrion Biopharma's Largest Competitors

A competitive analysis shows these companies are in the same general field as Kedrion Biopharma, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
RETINA GROUP INC. DBA RETINA CONSULTANTS	Southlake, TX	100
ROYAL CARE CERTIFIED HOME HEALTH CARE	Brooklyn, NY	92
KAISER FOUNDATION HOSPITALS	Oakland, CA	70
MOLINA HEALTHCARE	Long Beach, CA	57
MAYO CLINIC AMBULANCE	Rochester, MN	34
HAMASPIK CARE	Spring Valley, NY	29
NATIONAL MEDICAL CARE	Waltham, MA	27
HAH HOLDINGS	Chicago, IL	26
PROHEALTH PHYSICIANS P.C.	Farmington, CT	23

Nearby Competitors

These companies are similar in business line and location to Kedrion Biopharma. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
LIFE TECH	Livingston, NJ	100
NEW JERSEY UROLOGY	Bloomfield, NJ	41
REAL HOUSE	Montclair, NJ	34
ACCU REFERENCE MEDICAL LAB	Linden, NJ	31
KEDRION BIOPHARMA	Fort Lee, NJ	29
MOSES SCOTT ASSOCIATES LLC DBA	West Orange, NJ	18

Future Competition: Kedrion Biopharma's Fastest Growing Competitors

These companies are in the same general field as Kedrion Biopharma and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)